| Characterisation of the Immune Responses of 2 Experimental Malaria Vaccines (NCT00443131) | GlaxoSmithKline | 2007-03-26 |
| Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patients (NCT00421473) | Radboud University Medical Center | 2007-03-01 |
| Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax Malaria (NCT00440999) | Medicines for Malaria Venture | 2007-03-01 |
| Efficacy of Sulfadoxine-Pyrimethamine for Treating Malaria in Gabonese Children (NCT00453856) | Albert Schweitzer Hospital, Netherlands | 2007-03-01 |
| Intermittent Preventive Treatment (IPTp) Versus Rapid Diagnostic Testing (RDT) and Treatment of Malaria in Pregnancy (NCT00432367) | London School of Hygiene and Tropical Medicine | 2007-02-01 |
| Phase I Study of AMA1-C1/Alhydrogel® (Registered Trademark) + CPG 7909 Malaria Vaccine (NCT00427167) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-01-23 |
| Efficacy of RTS,S/AS01 Vaccine Against Episodes of Malaria Due to P. Falciparum Infection in Children. (NCT00380393) | GlaxoSmithKline | 2007-01-03 |
| Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients (NCT00422084) | Medicines for Malaria Venture | 2007-01-01 |
| Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria (NCT00414336) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-12-15 |
| Evaluation of Reproducibility of a Sporozoite Challenge Model for Plasmodium Vivax in Human Volunteers (NCT00367380) | Malaria Vaccine and Drug Development Center | 2006-12-01 |
| Azithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria. (NCT00367653) | Pfizer | 2006-11-01 |
| Parasite-based Diagnosis for Malaria in Uganda: Feasibility and Cost-Effectiveness (NCT00565071) | Makerere University | 2006-10-01 |
| GMZ2-Aluminum Hydroxide Phase I, Tübingen (NCT00397449) | European Vaccine Initiative | 2006-10-01 |
| Intermittent Preventive Treatment in Infant in Mali (NCT00766662) | University of Bamako | 2006-10-01 |
| Quinine vs. Artemether/Lumefantrine in Uncomplicated Malaria During Pregnancy (NCT00495508) | Epicentre | 2006-10-01 |
| Congenital and Neonatal Malaria in Mali (NCT00384267) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-10-01 |
| Sulfadoxine- Pyrimethamine Versus Weekly Chloroquine for Malaria Prevention in Children With Sickle Cell Anemia (NCT00399074) | Makerere University | 2006-10-01 |
| Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants (NCT00289185) | GlaxoSmithKline | 2006-09-27 |
| Sporozoite Challenge of Polyprotein Vaccinees (NCT00375128) | European Vaccine Initiative | 2006-09-01 |
| Safety and Efficacy of Methylene Blue Combined With Artesunate or Amodiaquine for Malaria Treatment in Children of Burkina Faso: a Pilot Study (NCT00354380) | Heidelberg University | 2006-09-01 |
| Pharmacokinetics, Efficacy, Gametocyte Carriage, Birth Outcomes Following Sulfadoxine-pyrimethamine Intermittent Presumptive Treatment in Pregnant Women (NCT00380146) | Professor Karen I Barnes | 2006-09-01 |
| A Study to Determine Whether 2 Investigational Malaria Vaccines Are Safe, Protective Against Malaria in Adults (NCT00385047) | U.S. Army Medical Research and Development Command | 2006-09-01 |
| PALUREA: Severe Imported Malaria in Adults (NCT00372684) | Assistance Publique - Hôpitaux de Paris | 2006-09-01 |
| Partially-blind (Observer-blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian Children (NCT00360230) | GlaxoSmithKline | 2006-08-30 |
| Efficacy and Safety of the Pediatric Formulation of Artemether- Lumefantrine in Children With Uncomplicated P. Falciparum Malaria. (NCT00386763) | Novartis | 2006-08-01 |
| Investigation of the Efficacy of Quinine Sulphate Administered Via Taste-Masked Pellets to Children With Falciparum Malaria (NCT00329134) | University Ghent | 2006-07-01 |
| Schistosome and Intestinal Worm Infections and Malaria Morbidity Among School and Pre-school Children in, Tanzania (NCT00347113) | DBL -Institute for Health Research and Development | 2006-07-01 |
| Use of Rapid Diagnostic Tests for Malaria Case Management in Kenya (NCT00336388) | Centers for Disease Control and Prevention | 2006-07-01 |
| IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria. (NCT00361114) | London School of Hygiene and Tropical Medicine | 2006-07-01 |
| Artemisinin-Based Combination Therapy: Clinical Trials in Cameroon (NCT00297882) | London School of Hygiene and Tropical Medicine | 2006-07-01 |
| Assessment of Anaemia Attributable to Schistosomiasis in School Children in Kenya: Mechanisms and Effect of Treatment (NCT00414479) | DBL -Institute for Health Research and Development | 2006-07-01 |
| Study of the Safety of Intravenous Artesunate (NCT00292942) | U.S. Army Medical Research and Development Command | 2006-06-12 |
| Treatment of Uncomplicated Childhood Malaria in Tanzania by Artemether+Lumefantrine - Efficacy and Genotyping (NCT00336375) | Karolinska University Hospital | 2006-06-01 |
| The Use of Homeopathic-Based Treatment Approaches to Reduce the Prevalence of Malaria in Depressed Communities (NCT00351013) | Malamed | 2006-06-01 |
| Bioavailability of the Fixed Combination of Amodiaquine and Artesunate Under Fed & Fasted Conditions (NCT00386503) | Sanofi | 2006-06-01 |
| Intermittent Preventive Treatment (IPTi) for the Prevention of Malaria and Anaemia in PNG Infants (NCT00285662) | Papua New Guinea Institute of Medical Research | 2006-06-01 |
| Comparison of Two Strategies for the Delivery of IPTc (NCT00376155) | London School of Hygiene and Tropical Medicine | 2006-05-01 |
| Analysis of the Immune Response to the Malaria Parasite in Mali, West Africa (NCT00346346) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-17 |
| Double-blind Study of Safety and Immunogenicity of Two Candidate Malaria Vaccines in Gabonese Children (NCT00307021) | GlaxoSmithKline | 2006-04-07 |
| Immune Response Regulation in People Infected Concurrently With Malarial and Filarial Parasites (NCT00341666) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-03 |
| Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America (NCT00312702) | U.S. Army Medical Research and Development Command | 2006-04-01 |
| Artesunate Plus Sulfadoxine-pyrimethamine Pharmacokinetics, Efficacy, Gametocytes Carriage and Birth Outcomes in Pregnant Women With Malaria (NCT00331708) | Professor Karen I Barnes | 2006-04-01 |
| Safety and Immunogenicity Study of the Malaria Vaccines FP9 PP and MVA PP (NCT00374998) | European Vaccine Initiative | 2006-04-01 |
| Effectiveness and Cost-Effectiveness of a Rapid Diagnostic Test for Malaria (NCT00317590) | Centro per le Malattie Tropicali | 2006-04-01 |
| Safety of and Immune Response to a Malaria Vaccine (MSP1 42-C1) With or Without CPG 7909 Adjuvant (NCT00320658) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-01 |
| ATAQ EASY: Artesunate + Amodiaquine Fixed Dose Combination in the Treatment of Uncomplicated Plasmodium Falciparum Malaria (NCT00316329) | Sanofi | 2006-03-01 |
| Prevention of P. Vivax Malaria During Pregnancy in Bolivia (NCT00290420) | Institut de Recherche pour le Developpement | 2006-03-01 |
| Safety and Efficacy Study of IV Artesunate to Treat Malaria (NCT00298610) | U.S. Army Medical Research and Development Command | 2006-03-01 |
| Study of Factors Involved in Resistance to Severe Malaria (NCT00368810) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-21 |
| Malaria Vaccine in Children in Mali (NCT00341250) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-01-19 |
| Drug Interaction Study Between Antimalarial and Anti-HIV Medications (NCT00266058) | University of California, San Francisco | 2005-12-01 |
| Relationship Between HIV and Malaria in Ugandan Children (NCT00356824) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-11-01 |
| Acceptability and Cost Effectiveness of Home Based Management of Fever: Different Strategies (NCT00259142) | DBL -Institute for Health Research and Development | 2005-11-01 |
| Control of Pregnancy Associated Malaria With Intermittent Preventive Treatment (NCT00258024) | DBL -Institute for Health Research and Development | 2005-11-01 |
| Rapid Diagnostic Tests (RDTs) for Malaria in Kampala, Uganda (NCT00327964) | University of California, San Francisco | 2005-10-01 |
| Efficacy, Safety and Pharmacokinetic of ArtequinTM P. Falciparum Malaria (NCT00243737) | Albert Schweitzer Hospital | 2005-10-01 |
| Efficacy and Safety of Amodiaquine and Amodiaquine-Artesunate (NCT00238017) | Charite University, Berlin, Germany | 2005-10-01 |
| Compliance to Artesunate-Amodiaquine Therapy for Uncomplicated Malaria in Rural Ghana (NCT00873938) | Kintampo Health Research Centre, Ghana | 2005-10-01 |
| Efficacy of Amodiaquine in the Treatment of Uncomplicated Falciparum Malaria in Young Children of Burkina Faso (NCT00261222) | Heidelberg University | 2005-09-01 |
| The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda (NCT00215267) | DBL -Institute for Health Research and Development | 2005-09-01 |
| Age of Exposure and Immunity to Malaria in Infants (NCT00231452) | Hospital Clinic of Barcelona | 2005-09-01 |
| Examine Safety and Immune Responses of GSK 257049 Vaccine When Administered to Infants Living in a Malaria-endemic Region (NCT00197028) | GlaxoSmithKline | 2005-08-23 |
| Examination of Protective Factors Against Severe Malaria (NCT00342043) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-08-02 |
| Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost Regimen (NCT00408668) | University of Oxford | 2005-08-01 |
| Contrast-Enhanced US of Spleen, Liver and Kidney (NCT00190281) | Assistance Publique - Hôpitaux de Paris | 2005-08-01 |
| Severe Malaria and Anti-malarial Drug Resistance in Cambodia (NCT00341003) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-07-22 |
| Field Evaluation of Plant-based Mosquito Control (NCT00116766) | London School of Hygiene and Tropical Medicine | 2005-07-01 |
| Chlorproguanil-Dapsone in Pregnant Women (NCT00126971) | Centers for Disease Control and Prevention | 2005-07-01 |
| Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinations (NCT00697892) | Fran Aweeka | 2005-07-01 |
| ACT MALI: Treatment of Malaria Based on Combination Therapies (NCT00452907) | Sanofi | 2005-07-01 |
| Antimalarial Drug Resistance in Mali (NCT00127998) | Centers for Disease Control and Prevention | 2005-07-01 |
| Evaluation of Home-Based Management of Fever in Urban Ugandan Children (NCT00115921) | London School of Hygiene and Tropical Medicine | 2005-07-01 |
| Intermittent Preventive Treatment During Pregnancy in Benin (NCT00274235) | Institut de Recherche pour le Developpement | 2005-07-01 |
| Efficacy of Fosmidomycin-Clindamycin for Treating Malaria in Gabonese Children (NCT00214643) | Albert Schweitzer Hospital, Netherlands | 2005-06-01 |
| Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function (NCT00386750) | Novartis Pharmaceuticals | 2005-06-01 |
| Arsucam® (Artesunate + Amiodaquine) Efficacy and TOLerance (NCT00445796) | Sanofi | 2005-06-01 |
| Effectiveness of Intermittent Preventive Treatment for Malaria in Children (NCT00119132) | London School of Hygiene and Tropical Medicine | 2005-06-01 |
| Kintampo Trial of Combination Therapy for Malaria (NCT00119145) | London School of Hygiene and Tropical Medicine | 2005-06-01 |
| CQSP in Malawi: Chloroquine and Sulfadoxine-pyrimethamine Efficacy for the Treatment of Malaria in Malawi (NCT00125489) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-05-01 |
| Long-Term Follow-up of Children for a 2-Year Period to Confirm the Safety and Immunogenicity of GSK 257049 Vaccine (NCT00323622) | GlaxoSmithKline | 2005-04-01 |
| Experimental Vaccine for Malaria (NCT00114010) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-04-01 |
| Tolerability and Efficacy of CD+A Compared to AQ+SP for the Treatment of P.Falciparum Malaria in Rwandan Children (NCT00461578) | London School of Hygiene and Tropical Medicine | 2005-04-01 |
| Efficacy and Cost Effectiveness of Malaria Diagnosis Procedures and the Rational Use of ACT in Zanzibar (NCT00549003) | Karolinska University Hospital | 2005-02-01 |
| A Randomised Trial of Rapid Diagnostic Tests in the Diagnosis of Malaria in Tanzania (NCT00146796) | London School of Hygiene and Tropical Medicine | 2005-01-01 |
| Food-Effect Bioavailability Study of AQ-13, a Candidate Antimalarial (NCT00455494) | Tulane University Health Sciences Center | 2005-01-01 |
| Kilimanjaro IPTi Drug Options Trial (NCT00158574) | London School of Hygiene and Tropical Medicine | 2005-01-01 |
| Improved Management and in-Hospital Mortality (NCT00465777) | Bandim Health Project | 2004-12-01 |
| Longitudinal Antimalarial Combinations in Uganda (NCT00123552) | University of California, San Francisco | 2004-11-01 |
| FMP2.1/AS02A: Rabies Vaccine Malaria-Experienced Adults in Bandiagara, Mali (NCT00349713) | U.S. Army Medical Research and Development Command | 2004-11-01 |
| Lapdap and Coartemether for Uncomplicated Malaria (NCT00118794) | London School of Hygiene and Tropical Medicine | 2004-09-01 |
| A Trial of Four Drug Regimens for the Prevention of Malaria in Senegalese Children (NCT00132548) | London School of Hygiene and Tropical Medicine | 2004-06-01 |
| Navrongo Drug Options for IPT in Pregnancy Trial (NCT00146783) | London School of Hygiene and Tropical Medicine | 2004-06-01 |
| Malaria Infection Diagnosed by Polymerase Chain Reaction (PCR) as a Means of Evaluating Pre-erythrocytic Candidate Malaria Vaccines (NCT00121823) | London School of Hygiene and Tropical Medicine | 2004-06-01 |
| The Effect of Paracetamol in the Treatment of Non-severe Malaria in Children in Guinea-Bissau (NCT00137566) | Bandim Health Project | 2004-05-01 |
| Eight Week Primaquine Regimen for the Treatment of Vivax Malaria (NCT00158587) | London School of Hygiene and Tropical Medicine | 2004-04-01 |
| Safe Pregnancy by Infectious Disease Control (NCT00489619) | NICHD Global Network for Women's and Children's Health | 2004-04-01 |
| A Trial of Improved Financial Access to Healthcare in Ghana (NCT00146692) | London School of Hygiene and Tropical Medicine | 2004-04-01 |
| A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered IM According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-endemic Region of Mozambique. (NCT00197067) | GlaxoSmithKline | 2004-03-15 |
| Intermittent Preventive Treatment With Antimalarials in Kenyan Infants (NCT00111163) | Centers for Disease Control and Prevention | 2004-03-01 |
| Mefloquine Bioequivalence Among 3 Commercially Available Tablets. (NCT00544024) | Centers for Disease Control and Prevention | 2004-03-01 |